Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves.

Abstract

Background:

Patients with severe tricuspid valve stenosis or dysfunction following degeneration of biological valve prosthesis in tricuspid position are complex, have substantial comorbidity, and very high surgical risk.

Case summary:

We report two cases with transcatheter tricuspid valve-in-valve implantation in patients with degenerated tricuspid bioprosthesis with transfemoral and transjugular access with Sapien 3 valve and MyVal, respectively.

Discussion:

In patients with high surgical risk, transcatheter tricuspid valve implantation is a good alternative. Careful consideration of optimal access site, device size, and delivery system is paramount. This case report demonstrates technically feasible and safe transcatheter valve-in-valve implantantion in tricuspid position and highlights the importance of meticulous procedure planning.

• Authors: Rebekka Vibjerg Jensen, Jesper Khedri Jensen, Evald Høj Christiansen, Mariann Tang, Jens Cosedis Nielsen, Christian Juhl Terkelsen
• Journal: European heart journal. Case reports (Eur Heart J Case Rep) Vol. 6 Issue 4 Pg. ytac131 (Apr 2022) ISSN: 2514-2119 [Electronic] England
• PMID: 35434509 (Publication Type: Case Reports)
• Copyright: © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology.